Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Lenvatinib
Related studies linked through entity extraction aliases.
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
- Status
- RECRUITING
- Phase
- PHASE1
HIM Typing Guides the Treatment of Advanced First-Line Triple-Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
- Status
- RECRUITING
- Phase
- PHASE2
Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
- Status
- RECRUITING
- Phase
- NA
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC
- Status
- COMPLETED
- Phase
- N/A
Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model
- Status
- RECRUITING
- Phase
- PHASE2
Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3